Lifeloc Technologies - Aktie

Lifeloc Technologies AAQS 2024

Lifeloc Technologies AAQS

2

Ticker

LCTC

ISIN

US53220Y2072

Lifeloc Technologies har en aktuel AAQS på 2. En høj AAQS kan betragtes som et positivt tegn på, at virksomheden udvikler sig succesfuldt. Investorerne kan forvente, at virksomheden er på rette spor mod at skabe overskud. På den anden side er det vigtigt at betragte AAQS for aktien Lifeloc Technologies i forhold til de opnåede overskud og sammenligne med andre virksomheder i samme branche. En høj AAQS er ikke en absolut garanti for en positiv fremtid. Det er kun på den måde, man kan få et komplet billede af virksomhedens præstationer. For bedre at kunne vurdere virksomhedens udvikling er det vigtigt at betragte AAQS i sammenligning med andre virksomheder i samme branche. Generelt bør investorer altid betragte en virksomheds AAQS i sammenhæng med andre nøgletal som overskud, EBIT, cash flow og andre for at træffe en velbaseret investeringsbeslutning.

Lifeloc Technologies Aktienanalyse

Hvad gør Lifeloc Technologies?

Lifeloc Technologies Inc is a company that has been a leader in the development of alcohol and drug testing devices for over 30 years. The company was founded in 1983 and is headquartered in Wheat Ridge, Colorado. Lifeloc focuses on manufacturing reliable and accurate alcohol and drug testing devices for applications in criminal and labor law, transportation, and healthcare. Lifeloc's business model is tailored to the needs of its customers. The company offers both direct sales and sales through a global distribution network. Lifeloc focuses on producing and selling alcohol and drug testing devices for drug activity monitoring, drug testing compliance for employees, drug analysis for government personnel, and medical testing centers. Lifeloc develops and manufactures a wide range of products for alcohol and drug testing. The company offers both individual devices and complete testing systems that cover a variety of methods for alcohol and drug testing. Products include alcohol testing devices for personal use and professional applications, drug testing devices for urine, saliva, and hair, and laboratory equipment for chemical analysis of drug substances. Lifeloc's various divisions cover applications in criminal and labor law, transportation, and healthcare. The company offers alcohol and drug testing devices for drug testing compliance to ensure that employees and service providers are tested for drugs and alcohol to ensure workplace safety. The company also offers products for correctional facilities to help offenders remember to stay sober. For the transportation sector, Lifeloc provides alcohol and drug testing devices for use in airplanes, ships, trucks, and other vehicles to ensure the safety of passengers and other road users. Lifeloc also offers products for use in healthcare, such as devices and test kits for drug testing analysis in hospitals and other medical facilities. Throughout its history, Lifeloc has overcome many challenges. A major milestone was the introduction of the Breathalyzer™ alcohol testing device in 1988, which is now considered an industry standard and used by government and law enforcement agencies worldwide. Another milestone was the introduction of Fingerscript™ technology in 2005, which allows for rapid on-site drug testing and is now used by many government agencies, law enforcement agencies, and companies. In conclusion, Lifeloc Technologies Inc plays a leading role as a pioneering company in the field of alcohol and drug testing worldwide. The company's business model is tailored to the needs of its customers, and it has developed a wide range of products that cover a variety of applications in criminal and labor law, transportation, and healthcare. Lifeloc has overcome many challenges over the years and is now a well-known company in the field of alcohol and drug testing worldwide. Lifeloc Technologies ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Ofte stillede spørgsmål om Lifeloc Technologies aktien

Aktiespareplaner tilbyder en attraktiv mulighed for investorer at opbygge formue på lang sigt. En af de største fordele er den såkaldte cost-average-effekt: Ved regelmæssigt at investere et fast beløb i aktier eller aktiefonde, køber man automatisk flere andele, når priserne er lave, og færre, når de er høje. Dette kan føre til en mere fordelagtig gennemsnitspris per andel over tid. Desuden giver aktiespareplaner også småinvestorer adgang til dyre aktier, da de kan deltage med små beløb. Den regelmæssige investering fremmer også en disciplineret investeringsstrategi og hjælper med at undgå følelsesladede beslutninger, som impulsiv køb eller salg. Derudover drager investorer fordel af den potentielle værdistigning af aktierne samt af udbytteudlodninger, der kan geninvesteres, hvilket forstærker renters rente effekten og dermed væksten af det investerede kapital.

Andere Kennzahlen von Lifeloc Technologies

Vores aktieanalyse af Lifeloc Technologies Omsætning-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Lifeloc Technologies Omsætning. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: